Identification of suberosin metabolites in human liver microsomes by high‐performance liquid chromatography combined with high‐resolution quadrupole–orbitrap mass spectrometer
Abstract Suberosin is a natural prenylated coumarin derivative isolated from Citropsis articulata. It has various pharmacological properties, especially as an anticoagulant, for which it has been used since antiquity. However, its metabolic pathway and metabolites have not yet been studied. Therefore, this study characterizes its metabolic pathway and metabolites in human liver microsomes (HLMs) using high‐resolution quadrupole–orbitrap mass spectrometry (HRMS/MS). Eight metabolites (M1–M8) were found, including three monohydroxylated (M1–M3), one hydrated (M4), three dihydroxylated (M5–M7), and one glucuronide conjugate (M8). Furthermore, forms of cytochrome P450 (CYPs) responsible for suberosin metabolism in HLMs were characterized. CYP1A2 was identified as a major enzyme for the production of M1 and M5 metabolites. The M2, M3, and M7 metabolites were predominantly generated by CYP2B6. M8 was the only phase II metabolite, identified as a glucuronide conjugate from either M1 or M2. This glucuronide conjugate may be the only promising metabolite from phase II metabolism. Phase I metabolism, especially hydroxylation, was found to provide a predominant metabolic pathway of suberosin in HLMs. Further studies should be conducted to explore the metabolites, examining their efficacy and their toxicity in an in vivo system..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:56 |
|---|---|
| Enthalten in: |
Journal of Mass Spectrometry - 56(2021), 4 |
| Beteiligte Personen: |
Paudel, Sanjita [VerfasserIn] |
|---|
| BKL: |
|---|
| Anmerkungen: |
© 2021 John Wiley & Sons, Ltd. |
|---|
| Umfang: |
12 |
|---|
| doi: |
10.1002/jms.4623 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY008979405 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY008979405 | ||
| 003 | DE-627 | ||
| 005 | 20230307182943.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230217s2021 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1002/jms.4623 |2 doi | |
| 028 | 5 | 2 | |a JMS_JMS4623.xml |
| 035 | |a (DE-627)WLY008979405 | ||
| 035 | |a (WILEY)JMS4623 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 082 | 0 | 4 | |a 570 |a 530 |q ASE |
| 084 | |a 33.07 |2 bkl | ||
| 084 | |a 35.26 |2 bkl | ||
| 100 | 1 | |a Paudel, Sanjita |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Identification of suberosin metabolites in human liver microsomes by high‐performance liquid chromatography combined with high‐resolution quadrupole–orbitrap mass spectrometer |
| 264 | 1 | |c 2021 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2021 John Wiley & Sons, Ltd. | ||
| 520 | |a Abstract Suberosin is a natural prenylated coumarin derivative isolated from Citropsis articulata. It has various pharmacological properties, especially as an anticoagulant, for which it has been used since antiquity. However, its metabolic pathway and metabolites have not yet been studied. Therefore, this study characterizes its metabolic pathway and metabolites in human liver microsomes (HLMs) using high‐resolution quadrupole–orbitrap mass spectrometry (HRMS/MS). Eight metabolites (M1–M8) were found, including three monohydroxylated (M1–M3), one hydrated (M4), three dihydroxylated (M5–M7), and one glucuronide conjugate (M8). Furthermore, forms of cytochrome P450 (CYPs) responsible for suberosin metabolism in HLMs were characterized. CYP1A2 was identified as a major enzyme for the production of M1 and M5 metabolites. The M2, M3, and M7 metabolites were predominantly generated by CYP2B6. M8 was the only phase II metabolite, identified as a glucuronide conjugate from either M1 or M2. This glucuronide conjugate may be the only promising metabolite from phase II metabolism. Phase I metabolism, especially hydroxylation, was found to provide a predominant metabolic pathway of suberosin in HLMs. Further studies should be conducted to explore the metabolites, examining their efficacy and their toxicity in an in vivo system. | ||
| 700 | 1 | |a Kim, Younah |4 aut | |
| 700 | 1 | |a Choi, Su Min |4 aut | |
| 700 | 1 | |a Kim, Ju‐Hyun |4 aut | |
| 700 | 1 | |a Bae, Jong‐Sup |4 aut | |
| 700 | 1 | |a Lee, Taeho |4 aut | |
| 700 | 1 | |a Lee, Sangkyu |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of Mass Spectrometry |g 56(2021), 4 |w (DE-627)WLY008975655 |x 10969888 |7 nnns |
| 773 | 1 | 8 | |g volume:56 |g year:2021 |g number:4 |g extent:12 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 936 | b | k | |a 33.07 |q ASE |
| 936 | b | k | |a 35.26 |q ASE |
| 951 | |a AR | ||
| 952 | |d 56 |j 2021 |e 4 |g 12 | ||